AstraZeneca (AZN) Beats Q3 Earnings And Revenue Estimates, Guides Higher
October 29, 2009 7:06 AM
AstraZeneca (AZN) reports Q3 $1.68 vs $1.39 consensus. AZN reports Q3 revenue of $8.2B vs $7.9B.
AstraZeneca guides FY09 EPS $6.20 to 6.40 vs Street view of $5.99.







